Lv2
200 积分 2022-02-17 加入
Therapeutic Peptides Control Strategy: Perspective on Current Industry Practices
1个月前
已完结
Quality Control of Peptide Drugs. Chiral Amino Acid Analysis versus Standard for Icatibant Acetate
1个月前
已完结
In Silico Method Development of Achiral and Chiral Tandem Column Reversed-phase Liquid Chromatography for Multicomponent Pharmaceutical Mixtures
1个月前
已完结
Characterization of Antisense Oligonucleotide Impurities by Ion-Pairing Reversed-Phase and Anion Exchange Chromatography Coupled to Hydrophilic Interaction Liquid Chromatography/Mass Spectrometry Using a Versatile Two-Dimensional Liquid Chromatography Setup
1个月前
已完结
Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities
1个月前
已完结
Use of Enzymes in the Manufacture of Active Pharmaceutical Ingredients—A Science and Safety-Based Approach To Ensure Patient Safety and Drug Quality
7个月前
已完结
Determination of d-amino acids by deuterium labelling and selected ion monitoring
8个月前
已完结
基于多步衍生化的GC-MS法测定胸腺法新中 D 型氨基酸
8个月前
已完结
Peptide chiral purity determination: hydrolysis in deuterated acid, derivatization with Marfey's reagent and analysis using high-performance liquid chromatography-electrospray ionization-mass spectrometry
8个月前
已完结
Oligonucleotide Anion Adduct Formation Using Negative Ion Electrospray Ion-Mobility Mass Spectrometry
9个月前
已完结
皖公网安备34019202002308
